Parents, providers in five countries approve of new two-dose HPV vaccination
November 5, 2018
Mothers of and health care providers for adolescent girls in Argentina, Malaysia, South Africa, South Korea and Spain prefer the two-dose, rather than three-dose, HPV vaccination schedule, according to research by epidemiology doctoral student Jessica Islam and others. The study brings hope that decreasing costs and doctor visits will lead to improved vaccination coverage and lower rates of HPV-associated cancers. Photo by Pan American Health Organization.
Law enforcement, gun retailers can provide temporary gun storage in times of suicide risk
October 30, 2018
A unique study co-authored by Dr. Robert Agans is the first to examine how local law enforcement agencies and gun retailers can offer temporary gun storage to prevent suicide in their communities. The study was published Oct. 11 in the American Journal of Public Health.
Doctoral students receive NIDA dissertation awards
October 21, 2018 Jessica Young and Sara Levintow, epidemiology doctoral students, have each received two-year R36 dissertation awards from the National Institute on Drug Abuse to support completion of their doctoral dissertation research projects in the field of drug use research.
Researchers examine relationship of campus policies to prevalence of campus sexual assault
October 21, 2018
An interdisciplinary team led by researchers at the Gillings School explored the critical issue of campus sexual assault in their article, "Starting the Conversation: Are Campus Sexual Assault Policies Related to the Prevalence of Campus Sexual Assault?" The work will be included in a special November issue of the Journal of Interpersonal Violence. Photo by Angel Leon.
Olshan, Desrosiers awarded CDC grant to study risk factors for birth defects
October 16, 2018
Drs. Andrew Olshan and Tania Desrosiers have been awarded a five-year, $4.37M CDC grant to support the N.C. Center for Birth Defects Research and Prevention. The researchers will team with other research centers to pool data and maximize the potential for discovery and impact related to birth defects. Photo by Derek Thomson.
ADHD medication use has increased, but some still do not receive needed treatment
October 11, 2018
Dr. Til Stürmer has co-authored a study showing that the use of medications to treat attention deficit hyperactivity disorder (ADHD) is on the rise in both adults and children worldwide, though at varying rates. The study, which analyzed the electronic patient records of more than 154 million people from 14 countries, was published in The Lancet Psychiatry.
is a co-author on the paper. The study between 2001 and 2015 and provides
FDA turns to scientists at UNC to fill knowledge gaps in the opioid crisis
October 5, 2018
The FDA has commissioned a set of visionary studies to answer critical questions about the opioid crisis in the U.S. A four-year award of up to $6.6 million to UNC-Chapel Hill and the University of Kentucky will ensure FDA’s readiness to evaluate innovative emerging technologies in pharmacology. Photo by Virginia Commonwealth University.
CDC awards $2M opioid research grant to UNC Injury Prevention Research Center
October 2, 2018
The CDC has awarded a three-year, $2 million research grant to UNC-Chapel Hill's Injury Prevention Research Center to support research on the prevention of opioid overdose. Dr. Shabbar Ranapurwala will lead the research. Photo by rawpixel.
New study finds gene variant predisposes people to Type 2 diabetes and also low body weight
October 2, 2018 A new study finds that a well-known gene variant linked to Type 2 diabetes also may predispose a person to being leaner or having a lower body weight. The findings are striking, as many individuals with Type 2 diabetes are obese. The work is one of the first examinations of the gene in a very large, representative sample of diverse Hispanics and Latinos. Photo courtesy of Rutgers School of Nursing.
MEASURE Evaluation awarded $35M+ to improve data and impact in fight against TB
September 30, 2018 USAID has awarded MEASURE Evaluation more than $35 million to strengthen tuberculosis data and knowledge sharing worldwide. Dr. Jim Thomas is principal investigator for the work. Photo by the Advocacy Project (Zimbabwe).
